Astera Labs (NASDAQ:ALAB) Price Target Cut to $400.00 by Analysts at Royal Bank Of Canada

Key Points

• Royal Bank of Canada cut its Astera Labs price target from $500 to $400 but maintained an “outperform” rating; the new target implies 85.55% upside from the stock’s reported price.
• Astera reported quarterly revenue of $584.9 million, up 153.6% year over year, and EPS of $1.32, beating analyst expectations for both metrics.
• Analyst opinions remain mixed: MarketBeat reports a “Moderate Buy” consensus and a $319.11 average target, while ALAB shares traded at $215.57 after falling sharply from their 12-month high.

Astera Labs (NASDAQ:ALAB - Get Free Report) had its price target cut by equities researchers at Royal Bank Of Canada from $500.00 to $400.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage presently has an "outperform" rating on the stock. Royal Bank Of Canada's price objective suggests a potential upside of 85.55% from the company's current price.

ALAB has been the topic of several other research reports. TD Cowen dropped their target price on Astera Labs from $375.00 to $300.00 and set a "hold" rating on the stock in a report on Monday, October 19th. Citigroup downgraded Astera Labs from a "buy" rating to a "hold" rating in a research note on Friday, October 9th. Barclays boosted their price target on Astera Labs from $200.00 to $325.00 and gave the stock an "equal weight" rating in a research report on Monday, July 20th. UBS Group reiterated a "neutral" rating and set a $290.00 price objective on shares of Astera Labs in a research note on Wednesday. Finally, Zacks Research downgraded Astera Labs from a "strong-buy" rating to a "hold" rating in a report on Monday, October 5th. Twelve investment analysts have rated the stock with a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $319.11.

Astera Labs Price Performance

ALAB stock traded down $18.05 during midday trading on Wednesday, hitting $215.57. The company's stock had a trading volume of 3,519,845 shares, compared to its average volume of 5,087,875. Astera Labs has a twelve month low of $97.89 and a twelve month high of $499.48. The company's fifty day moving average price is $306.13 and its 200 day moving average price is $255.53. The stock has a market capitalization of $37.40 billion, a P/E ratio of 107.69 and a beta of 3.85.

Astera Labs (NASDAQ:ALAB - Get Free Report) last issued its quarterly earnings results on Tuesday, November 3rd. The company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.19 by $0.13. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $584.90 million for the quarter, compared to analysts' expectations of $550.78 million. During the same period in the previous year, the firm posted $0.49 EPS. The company's revenue for the quarter was up 153.6% on a year-over-year basis. Equities analysts expect that Astera Labs will post 2.71 EPS for the current fiscal year.

Insider Transactions at Astera Labs

In other news, Director Manuel Alba sold 183,000 shares of the firm's stock in a transaction that occurred on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the sale, the director directly owned 253,863 shares of the company's stock, valued at $71,114,642.19. This trade represents a 41.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the business's stock in a transaction that occurred on Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer directly owned 1,266,665 shares in the company, valued at $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders have sold 408,558 shares of company stock valued at $127,306,034. Company insiders own 10.40% of the company's stock.

Hedge Funds Weigh In On Astera Labs

Several large investors have recently modified their holdings of the stock. Amazon Com Inc. purchased a new position in Astera Labs in the 2nd quarter valued at approximately $134,172,000. Edgestream Partners L.P. purchased a new stake in shares of Astera Labs during the first quarter worth $1,891,000. Lido Advisors LLC lifted its position in shares of Astera Labs by 123.4% during the first quarter. Lido Advisors LLC now owns 27,477 shares of the company's stock worth $3,012,000 after acquiring an additional 15,180 shares in the last quarter. Silvant Capital Management LLC bought a new position in shares of Astera Labs in the second quarter worth $11,277,000. Finally, Sanders Morris Harris LLC bought a new position in shares of Astera Labs in the third quarter worth $4,821,000. 60.47% of the stock is owned by institutional investors.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Q3 revenue reached a record $584.9 million, up 154% year over year, while EPS of $1.32 topped the $1.19 consensus. Scorpio fabric switches became Astera’s largest product family, with volume production of the Scorpio X-Series driving growth. Astera Labs Q3 results
• Positive Sentiment: Management sees Q4 revenue of $730 million to $750 million and is pursuing additional growth in optical connectivity, memory and rack-scale AI systems. Northland Securities upgraded ALAB to “outperform” with a $315 target. Earnings call and growth highlights
• Neutral Sentiment: Analyst views diverged: Susquehanna cut its price target to $258 and kept a “neutral” rating, while Northland upgraded the shares. The split reflects uncertainty about the stock’s outlook even as business growth remains strong. Susquehanna rating
• Negative Sentiment: ALAB has fallen sharply from its 12-month high and recently broke below key technical levels. That momentum and the stock’s high valuation may help explain why investors have not fully rewarded the earnings and guidance beat. Recent share-price and technical weakness

Astera Labs Company Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company's portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.